Michelle Dawson posts
Structured cited links
Resilient Pharmaceuticals, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2014). Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults. ClinicalTrials.gov. Resilient Pharmaceuticals.
Abstract
The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective at reducing social anxiety in adults with autism. The main questions it aims to answer are: * Do two sessions of MDMA-assisted therapy reduce social anxiety? * What dose of MDMA is most effective at reducing social anxiety? Researchers will compare two blinded sessions of MDMA-assisted therapy to two blinded sessions of placebo with therapy. Participants will undergo three non-drug preparatory therapy sessions before the first blinded medication session. After each medication session, participants will undergo three non-drug integrative therapy sessions. In Stage 2, participants who received placebo with therapy in the first two blinded sessions will be able to undergo two sessions with MDMA-assisted therapy.